The SkincAIr consortium is pleased to announce that its clinical validation study, “Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers (SkincAIr)”, has officially been registered on ClinicalTrials.gov under the identifier NCT07506967.

The study addresses a major public health challenge: approximately 1.8 billion people worldwide are affected by skin-related neglected tropical diseases, particularly in poor and rural communities where access to specialist care is limited. SkincAIr is testing whether a mobile app powered by artificial intelligence can help frontline healthcare workers improve the early detection, diagnosis, and management of skin NTDs in real-world primary care settings.

Read the press release for more information: https://zenodo.org/records/19677720

If you want to always stay updated about our project, follow us on  LinkedInFacebookX and Bluesky!

Join the SkincAir movement

Be part of a digital health revolution that puts AI in the hands of community health heroes.


This project has received funding from the European Union’s Horizon Europe research and innovation programme and Global Health EDCTP3 Join undertaking programme under grant agreement No. 101190743 – 2 . Views and opinions expressed are however those of the author(s) only. Neither the European Union nor the granting authority can be held responsible for them.

© SkincAIr. All rights reserved.